Cargando…
Potential Role of Metabolic Intervention in the Management of Advanced Differentiated Thyroid Cancer
Well-differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy that has an excellent prognosis with a 5-year survival rate of about 98%. However, approximately 50% of the patients with DTC who present with distant metastases (advanced DTC) die from the disease within 5 years of...
Autores principales: | Tella, Sri Harsha, Kommalapati, Anuhya, Esquivel, Mary Angelynne, Correa, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524671/ https://www.ncbi.nlm.nih.gov/pubmed/28791253 http://dx.doi.org/10.3389/fonc.2017.00160 |
Ejemplares similares
-
Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017) -
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition
por: Tella, Sri Harsha, et al.
Publicado: (2015) -
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
por: Tella, Sri Harsha, et al.
Publicado: (2019) -
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021) -
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
por: Storandt, Michael H, et al.
Publicado: (2022)